ABCA1 and coronary artery disorder: The changes of ABCA1-mediated cholesterol efflux between CAD-abs and CAD-smo after a 3 month follow-up were still significantly different (3.33 ± 3.72% vs. 0.64 ± 1.97%; p = 0.036) (Fig. 3F).